Other OTC Pharmaceuticals (Pharmacies) - Sierra Leone

  • Sierra Leone
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$0.80m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.92%, resulting in a market volume of US$0.88m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.09 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Sierra Leone has been experiencing significant growth in recent years.

Customer preferences:
Sierra Leonean customers have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience and accessibility of these products. OTC medications are readily available in pharmacies and do not require a prescription, allowing customers to easily purchase them for common ailments and minor health issues. Additionally, OTC medications are often more affordable than prescription drugs, making them a popular choice for individuals seeking cost-effective healthcare solutions.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals market in Sierra Leone is the increasing demand for products related to personal hygiene and wellness. This trend can be attributed to the growing awareness among consumers about the importance of maintaining good hygiene practices and taking care of their overall well-being. As a result, products such as hand sanitizers, vitamins, and supplements are in high demand. The COVID-19 pandemic has further accelerated this trend, as individuals are now more conscious of the need to protect themselves from infections and maintain a strong immune system. Another trend in the market is the rising popularity of traditional and herbal medicines. Sierra Leone has a rich tradition of using natural remedies for various health conditions, and this has translated into a demand for herbal and traditional OTC pharmaceutical products. Customers are increasingly seeking out products that are derived from natural sources and have fewer side effects compared to synthetic medications. This trend is also driven by a growing interest in alternative medicine and a desire for more holistic approaches to healthcare.

Local special circumstances:
Sierra Leone is a developing country with a healthcare system that faces several challenges. Limited access to healthcare facilities, especially in rural areas, has led to an increased reliance on pharmacies for basic healthcare needs. Pharmacies often serve as the first point of contact for individuals seeking medical advice and treatment. This reliance on pharmacies has contributed to the growth of the Other OTC Pharmaceuticals market in Sierra Leone, as customers turn to these establishments for a wide range of healthcare products and services.

Underlying macroeconomic factors:
The growth of the Other OTC Pharmaceuticals market in Sierra Leone can also be attributed to favorable macroeconomic factors. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and consumer spending. As individuals have more money to spend on healthcare products, the demand for OTC pharmaceuticals has risen. Additionally, the government has taken steps to improve healthcare infrastructure and access to essential medicines, which has further supported the growth of the market. In conclusion, the Other OTC Pharmaceuticals market in Sierra Leone is developing due to customer preferences for accessible and affordable healthcare solutions, as well as the growing demand for personal hygiene and wellness products. The popularity of traditional and herbal medicines also contributes to the market's growth. Local special circumstances, such as limited access to healthcare facilities, drive individuals to rely on pharmacies for basic healthcare needs. Favorable macroeconomic factors, including economic growth and government initiatives, further support the market's development.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)